Home > Income Statement > INDO US BIOTECH

INDO US BIOTECH
Revenue

    Back to Income Statement
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹104 Cr₹73 Cr₹62 Cr₹50 Cr₹40 Cr

What is the latest Revenue of INDO US BIOTECH ?

The latest Revenue ratio of INDO US BIOTECH is ₹104 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹104 Cr
Mar2024₹73 Cr
Mar2023₹62 Cr
Mar2022₹50 Cr
Mar2021₹40 Cr

How is Revenue of INDO US BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹104 Cr
42.56
Mar2024 ₹73 Cr
17.96
Mar2023 ₹62 Cr
23.36
Mar2022 ₹50 Cr
24.86
Mar2021 ₹40 Cr -

Compare Revenue of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹285.4 Cr -4% 12.6% -36.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,825.3 Cr -4.7% -1.3% -6% Stock Analytics
KAVERI SEED COMPANY ₹3,968.5 Cr -6.4% -17.6% -18.5% Stock Analytics
VENKYS (INDIA) ₹1,898.1 Cr -2.7% -12.1% -18.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹942.1 Cr -1.6% 0.8% -38.4% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹367.5 Cr -4.6% -10.3% -22.9% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-4%

12.6%

-36.3%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses